Form 4: Community Health Systems EVP Reports Equity Transactions

Community Health Systems EVP Kevin Stockton reported significant stock option exercises, restricted stock vesting, and new equity grants.

Summary

• Kevin A. Stockton, Executive Vice President of Operations & Development for Community Health Systems Inc. (CYH), reported several equity transactions on March 1, 2026.
• 50,000 performance-based restricted shares vested, indicating 100% achievement of performance objectives for the 2023-2025 period.
• Mr. Stockton received a new grant of 30,000 restricted shares, which will vest in one-third increments on the first, second, and third anniversaries of the grant date.
• A new grant of 60,000 performance-based restricted shares was awarded for the 2026-2028 performance period, with vesting contingent on achieving Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Same-Store Net Revenue Growth targets (50% each).
• Mr. Stockton also received a new grant of 30,000 stock options with an exercise price of $3.46, vesting in one-third increments over three years and expiring on February 29, 2036.
• To cover tax liabilities related to the vesting, 35,573 shares of common stock were disposed of at a price of $3.46 per share.
• Following these transactions, Mr. Stockton's direct beneficial ownership of common stock is 208,290 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting the successful achievement of past performance targets and the continued alignment of executive incentives with future company growth through new equity grants.

Positives

• The successful vesting of 50,000 performance-based restricted shares at 100% of the target indicates the company achieved its performance objectives for the 2023-2025 period.
• New equity grants, including 30,000 restricted shares, 60,000 performance-based restricted shares, and 30,000 stock options, align executive incentives with the company's future performance and long-term shareholder value.

Negatives

• A disposition of 35,573 shares of common stock occurred to cover tax liabilities associated with the vesting of equity awards, which is a routine event but reduces direct share ownership.

Risks

• The vesting of 60,000 performance-based restricted shares for the 2026-2028 period is contingent on achieving specific Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Same-Store Net Revenue Growth targets, with vesting ranging from 0% to 200% based on achievement.
• Other outstanding performance-based restricted shares for the 2024-2026 (80,000 shares) and 2025-2027 (80,000 shares) performance periods are also subject to the attainment of certain performance objectives, carrying the risk of non-vesting if targets are not met.

Future Outlook

The new performance-based restricted shares for the 2026-2028 period are explicitly tied to future Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Same-Store Net Revenue Growth targets, signaling management's strategic focus on these key operational and financial metrics for future performance.

Management Comments

• The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.
• The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target.

Industry Context

StockSavvy.ai notes that executive equity grants and performance-based awards are standard practice in the healthcare services industry, aligning executive incentives with long-term shareholder value and operational performance. The focus on metrics like Adjusted EBITDA Growth and Net Revenue Growth is particularly critical for hospital operators like Community Health Systems, reflecting key drivers of financial health and market position within the competitive healthcare landscape.

Comparison to Industry Standards

• The use of performance-based restricted shares tied to specific financial metrics such as Adjusted EBITDA Growth and Net Revenue Growth is a common practice among publicly traded healthcare providers, similar to compensation structures observed at competitors like HCA Healthcare (HCA) or Tenet Healthcare (THC), which also link executive compensation to operational and financial performance.
• The vesting schedule for restricted stock and stock options, typically in one-third increments over three years, is standard for executive compensation plans across various industries, including healthcare, ensuring long-term retention and alignment of executive interests.
• The disposition of shares to cover tax liabilities upon vesting is a routine and expected event for executives receiving equity compensation and is consistent with practices observed at comparable companies in the sector.

Corporate Governance

Stakeholder Impact

• Shareholders: The successful vesting of performance-based awards indicates the achievement of past company performance targets, which is generally positive. New equity grants align executive interests with long-term shareholder value creation. The tax-related sale is a minor and expected dilution event.
• Employees: While no direct impact is mentioned, the executive compensation structure and achievement of performance targets can indirectly influence overall company morale and strategic direction.

Next Steps

• Monitoring of Community Health Systems' performance against the 2026-2028 performance objectives (Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Same-Store Net Revenue Growth) for the newly granted performance-based restricted shares.
• Future vesting events for the newly granted restricted stock and stock options will occur on their respective anniversary dates.
• Future vesting events for the 2024-2026 and 2025-2027 performance-based restricted shares will depend on the attainment of their specific performance objectives.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation activities, including the vesting of performance-based awards due to achieved targets and new equity grants. While the achievement of performance targets is a positive indicator, these are standard events and do not present new information that would fundamentally alter the investment thesis for Community Health Systems. The transactions reflect ongoing compensation structures and insider ownership adjustments rather than a strong buy or sell signal, warranting a 'hold' recommendation for seasoned investors.

Keywords

Community Health Systems, CYH, Form 4, Insider Trading, Executive Compensation, Equity Grant, Restricted Stock, Stock Options, Performance Shares, Kevin Stockton